Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Marinus Pharmaceuticals, Inc. (MRNS) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Marinus Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1267813.
Total stock buying since 2014: $19,494,942.
Total stock sales since 2014: $14,025,563.
Total stock option exercises since 2014: $633,112.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 3,210 | $1,733 | 0 | $0 |
| 2024 | 5,933 | $6,526 | 50,874 | $248,291 | 50,000 | $214,000 |
| 2023 | 0 | $0 | 19,566 | $178,091 | 0 | $0 |
| 2021 | 0 | $0 | 44,606 | $785,783 | 35,927 | $149,456 |
| 2020 | 0 | $0 | 2,380 | $4,879 | 0 | $0 |
| 2019 | 100,000 | $125,000 | 34,845 | $154,890 | 31,662 | $32,928 |
| 2018 | 0 | $0 | 12,566 | $83,804 | 0 | $0 |
| 2017 | 0 | $0 | 1,272,547 | $10,205,298 | 0 | $0 |
| 2016 | 0 | $0 | 1,361,299 | $2,078,274 | 0 | $0 |
| 2015 | 0 | $0 | 30,000 | $284,520 | 146,794 | $152,665 |
| 2014 | 2,420,427 | $19,363,416 | 0 | $0 | 80,830 | $84,063 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-01 | 0 | $0 | 3,210 | $1,733 | 0 | $0 |
| 2024-08 | 5,933 | $6,526 | 29,071 | $32,885 | 0 | $0 |
| 2024-03 | 0 | $0 | 0 | $0 | 50,000 | $214,000 |
| 2024-02 | 0 | $0 | 21,803 | $215,406 | 0 | $0 |
| 2023-08 | 0 | $0 | 16,725 | $159,551 | 0 | $0 |
| 2023-02 | 0 | $0 | 2,841 | $18,540 | 0 | $0 |
| 2021-03 | 0 | $0 | 44,606 | $785,783 | 35,927 | $149,456 |
| 2020-01 | 0 | $0 | 2,380 | $4,879 | 0 | $0 |
| 2019-12 | 100,000 | $125,000 | 0 | $0 | 0 | $0 |
| 2019-05 | 0 | $0 | 24,211 | $121,781 | 0 | $0 |
| 2019-03 | 0 | $0 | 0 | $0 | 31,662 | $32,928 |
| 2019-01 | 0 | $0 | 10,634 | $33,109 | 0 | $0 |
| 2018-01 | 0 | $0 | 12,566 | $83,804 | 0 | $0 |
| 2017-12 | 0 | $0 | 1,272,547 | $10,205,298 | 0 | $0 |
| 2016-10 | 0 | $0 | 750,683 | $1,042,698 | 0 | $0 |
| 2016-08 | 0 | $0 | 294,737 | $442,105 | 0 | $0 |
| 2016-07 | 0 | $0 | 315,879 | $593,471 | 0 | $0 |
| 2015-09 | 0 | $0 | 0 | $0 | 39,550 | $41,132 |
| 2015-07 | 0 | $0 | 0 | $0 | 56,636 | $58,901 |
| 2015-06 | 0 | $0 | 0 | $0 | 3,000 | $3,120 |
| 2015-04 | 0 | $0 | 30,000 | $284,520 | 30,000 | $31,200 |
| 2015-03 | 0 | $0 | 0 | $0 | 17,608 | $18,312 |
| 2014-10 | 0 | $0 | 0 | $0 | 80,830 | $84,063 |
| 2014-08 | 2,420,427 | $19,363,416 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-01-21 | Johnson Marvin | Sale | 1,610 | .54 | 869 |
| 2025-01-21 | Ezickson Elan | Sale | 1,600 | .54 | 864 |
| 2024-08-14 | Braunstein Scott (CHAIRMAN AND CEO) | Buy | 5,933 | 1.10 | 6,526 |
| 2024-08-05 | Shafer Christina (CHIEF COMMERCIAL OFFICER) | Sale | 3,820 | 1.14 | 4,354 |
| 2024-08-05 | Pfanstiel Steven (CFO AND COO) | Sale | 4,657 | 1.13 | 5,262 |
| 2024-08-05 | Hulihan Joseph (CHIEF MEDICAL OFFICER) | Sale | 4,828 | 1.13 | 5,455 |
| 2024-08-05 | Braunstein Scott (CHAIRMAN AND CEO) | Sale | 12,145 | 1.13 | 13,723 |
| 2024-08-05 | Manning Martha E (SVP, GEN. COUNSEL & CORP. SEC.) | Sale | 3,621 | 1.13 | 4,091 |
| 2024-03-27 | Braunstein Scott (CHAIRMAN AND CEO) | Option Ex | 50,000 | 4.28 | 214,000 |
| 2024-02-20 | Shafer Christina (CHIEF COMMERCIAL OFFICER) | Sale | 2,153 | 9.56 | 20,582 |
| 2024-02-20 | Manning Martha E (SVP, GEN. COUNSEL & CORP. SEC.) | Sale | 1,894 | 9.57 | 18,125 |
| 2024-02-16 | Pfanstiel Steven (CFO AND COO) | Sale | 3,092 | 9.97 | 30,827 |
| 2024-02-16 | Hulihan Joseph (CHIEF MEDICAL OFFICER) | Sale | 2,814 | 9.98 | 28,083 |
| 2024-02-16 | Braunstein Scott (CHAIRMAN AND CEO) | Sale | 11,850 | 9.94 | 117,789 |
| 2023-08-08 | Shafer Christina (CHIEF COMMERCIAL OFFICER) | Sale | 11 | 8.93 | 98 |
| 2023-08-08 | Pfanstiel Steven (CFO AND COO) | Sale | 14 | 8.93 | 125 |
| 2023-08-08 | Hulihan Joseph (CHIEF MEDICAL OFFICER) | Sale | 13 | 8.93 | 116 |
| 2023-08-08 | Braunstein Scott (CHAIRMAN AND CEO) | Sale | 30 | 8.94 | 268 |
| 2023-08-08 | Manning Martha E (SVP, GEN. COUNSEL & CORP. SEC.) | Sale | 11 | 8.93 | 98 |
| 2023-08-07 | Shafer Christina (CHIEF COMMERCIAL OFFICER) | Sale | 2,385 | 9.52 | 22,705 |
| 2023-08-07 | Pfanstiel Steven (CFO AND COO) | Sale | 2,790 | 9.54 | 26,616 |
| 2023-08-07 | Hulihan Joseph (CHIEF MEDICAL OFFICER) | Sale | 2,889 | 9.55 | 27,589 |
| 2023-08-07 | Braunstein Scott (CHAIRMAN AND CEO) | Sale | 6,413 | 9.55 | 61,244 |
| 2023-08-07 | Manning Martha E (SVP, GEN. COUNSEL & CORP. SEC.) | Sale | 2,169 | 9.54 | 20,692 |
| 2023-02-06 | Austin Charles | Sale | 1,073 | 6.49 | 6,963 |
| 2023-02-06 | Fischer Seth H. Z. | Sale | 1,018 | 6.54 | 6,657 |
| 2023-02-06 | Ezickson Elan | Sale | 750 | 6.56 | 4,920 |
| 2021-03-15 | Vitullo Nicole | Sale | 4,250 | 15.87 | 67,447 |
| 2021-03-09 | Smith Edward F (Former VP, CFO & Treasurer) | Sale | 40,356 | 17.80 | 718,336 |
| 2021-03-09 | Smith Edward F (Former VP, CFO & Treasurer) | Option Ex | 35,927 | 4.16 | 149,456 |
| 2020-01-30 | Smith Edward F (CFO) | Sale | 2,380 | 2.05 | 4,879 |
| 2019-12-13 | Braunstein Scott (Chief Executive Officer) | Buy | 100,000 | 1.25 | 125,000 |
| 2019-05-16 | Smith Edward F (CFO) | Sale | 24,211 | 5.03 | 121,781 |
| 2019-03-18 | Cashman Christopher Michael (CEO) | Option Ex | 31,662 | 1.04 | 32,928 |
| 2019-01-29 | Smith Edward F (CFO) | Sale | 2,492 | 3.06 | 7,625 |
| 2019-01-28 | Cashman Christopher Michael (CEO) | Sale | 8,142 | 3.13 | 25,484 |
| 2018-01-29 | Smith Edward F (CFO) | Sale | 3,000 | 7.91 | 23,730 |
| 2018-01-18 | Cashman Christopher Michael (CEO) | Sale | 9,566 | 6.28 | 60,074 |
| 2017-12-19 | Koppel Adam (10% Owner) | Sale | 150,000 | 7.36 | 1,104,450 |
| 2017-12-18 | Koppel Adam (10% Owner) | Sale | 300,000 | 7.50 | 2,251,500 |
| 2017-12-15 | Koppel Adam (10% Owner) | Sale | 822,547 | 8.33 | 6,849,348 |
| 2016-10-20 | Powell Michael | Sale | 750,683 | 1.39 | 1,042,698 |
| 2016-08-08 | Canaan Partners Vii Llc (10% Owner) | Sale | 19,950 | 1.50 | 29,925 |
| 2016-08-05 | Canaan Partners Vii Llc (10% Owner) | Sale | 129,204 | 1.50 | 193,806 |
| 2016-08-04 | Canaan Partners Vii Llc (10% Owner) | Sale | 3,329 | 1.50 | 4,993 |
| 2016-08-03 | Canaan Partners Vii Llc (10% Owner) | Sale | 142,254 | 1.50 | 213,381 |
| 2016-07-29 | Canaan Partners Vii Llc (10% Owner) | Sale | 24,540 | 1.71 | 41,963 |
| 2016-07-27 | Canaan Partners Vii Llc (10% Owner) | Sale | 209 | 1.80 | 376 |
| 2016-07-26 | Canaan Partners Vii Llc (10% Owner) | Sale | 20,380 | 1.81 | 36,887 |
| 2016-07-25 | Canaan Partners Vii Llc (10% Owner) | Sale | 137,617 | 1.86 | 255,967 |
| 2016-07-22 | Canaan Partners Vii Llc (10% Owner) | Sale | 133,133 | 1.94 | 258,278 |
| 2015-09-28 | Bloch Stephen M (Director) | Option Ex | 39,550 | 1.04 | 41,132 |
| 2015-07-16 | Mayleben Timothy M (Director) | Option Ex | 42,550 | 1.04 | 44,252 |
| 2015-07-01 | Cashman Christopher Michael (President and CEO) | Option Ex | 14,086 | 1.04 | 14,649 |
| 2015-06-10 | Bloch Stephen M (Director) | Option Ex | 3,000 | 1.04 | 3,120 |
| 2015-04-21 | Farfel Gail M (Chief Clinical Dev & Reg Offic) | Sale | 30,000 | 9.48 | 284,520 |
| 2015-04-21 | Farfel Gail M (Chief Clinical Dev & Reg Offic) | Option Ex | 30,000 | 1.04 | 31,200 |
| 2015-03-06 | Cashman Christopher Michael (PRESIDENT AND CEO) | Option Ex | 17,608 | 1.04 | 18,312 |
| 2014-10-08 | Cashman Christopher Michael (PRESIDENT AND CEO) | Option Ex | 80,830 | 1.04 | 84,063 |
| 2014-08-05 | Canaan Partners Vii Llc (Director) | Buy | 625,000 | 8.00 | 5,000,000 |
| 2014-08-05 | Bloch Stephen M (Director) | Buy | 625,000 | 8.00 | 5,000,000 |
| 2014-08-05 | Powell Michael (10% Owner) | Buy | 750,683 | 8.00 | 6,005,464 |
| 2014-08-05 | Vitullo Nicole (Director) | Buy | 419,744 | 8.00 | 3,357,952 |
Insider trading activities including stock purchases, stock sales, and option exercises of MRNS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Marinus Pharmaceuticals, Inc. (symbol MRNS, CIK number 1267813) see the Securities and Exchange Commission (SEC) website.